Lipocalin-2 and intestinal diseases
Authors:
Open Access
- 14 December 2024
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 30 (46) , 4864-4879
Abstract
Dysfunction of the intestinal barrier is a prevalent phenomenon observed across a spectrum of diseases, encompassing conditions such as mesenteric artery dissection, inflammatory bowel disease, cirrhosis, and sepsis. In these pathological states, the integrity of the intestinal barrier, which normally serves to regulate the selective passage of substances between the gut lumen and the bloodstream, becomes compromised. This compromised barrier function can lead to a range of adverse consequences, including increased permeability to harmful substances, the translocation of bacteria and their products into systemic circulation, and heightened inflammatory responses within the gut and beyond. Understanding the mechanisms underlying intestinal barrier dysfunction in these diverse disease contexts is crucial for the development of targeted therapeutic interventions aimed at restoring barrier integrity and ameliorating disease progression. Lipocalin-2 (LCN2) expression is significantly upregulated during episodes of intestinal inflammation, making it a pivotal indicator for gauging the extent of such inflammatory processes. Notably, however, LCN2 derived from distinct cellular sources, whether intestinal epithelial cells or immune cells, exhibits notably divergent functional characteristics. Furthermore, the multifaceted nature of LCN2 is underscored by its varying roles across different diseases, sometimes even demonstrating contradictory effects.Keywords
This publication has 136 references indexed in Scilit:
- Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating ironNature, 2004
- Neutrophil Gelatinase-Associated Lipocalin Is Up-Regulated in Human Epithelial Cells by IL-1β, but Not by TNF-αThe Journal of Immunology, 2003
- An Iron Delivery Pathway Mediated by a LipocalinMolecular Cell, 2002
- The Neutrophil Lipocalin NGAL Is a Bacteriostatic Agent that Interferes with Siderophore-Mediated Iron AcquisitionMolecular Cell, 2002
- Megalin and cubilin: multifunctional endocytic receptorsNature Reviews Molecular Cell Biology, 2002
- Hyperglycemia-induced Production of Acute Phase Reactants in Adipose TissueJournal of Biological Chemistry, 2001
- Interleukin-9 induces 24P3 lipocalin gene expression in murine T cell lymphomas.2001
- Ligand Preference Inferred from the Structure of Neutrophil Gelatinase Associated LipocalinBiochemistry, 2000
- Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases.Gut, 1996
- Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils.1994